IP Library › Patent Application 13662079
Patent Application
App. No. 13/662,079

Burst Drug Release Compositions

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/662,079
Abstract

Solid dose compositions comprising at least one low solubility pharmaceutically active ingredient, at least one low solubility filler and at least one controlled release agent. comprising at least one poorly soluble pharmaceutically active ingredient, a insoluble binder and at least one controlled release agent along with a method of manufacturing said composition are disclosed. Methods for making these compositions are also disclosed.

Claims (16)

1 . A solid dose composition comprising at least one low solubility pharmaceutically active ingredient, at least one low solubility filler and at least one controlled release agent.

2 . A solid dose composition of claim 1 wherein the low solubility pharmaceutically active ingredient is ibuprofen and the low solubility filler is microcrystalline cellulose.

3 . A method of manufacturing a solid dose composition at least one low solubility pharmaceutically active ingredient, at least one low solubility filer and at least one controlled release agent wherein at least one low solubility pharmaceutically active ingredient is premixed using wet granulation prior to tableting.

4 . A solid dose composition of claim 1 wherein the apparent viscosity of the controlled release agent is between 100 and 100,000 centipoise.

5 . A solid dose composition of claim 1 further comprising two layers wherein the layers dissolve at different rates.

6 . A solid dose composition of claim 5 wherein the low solubility pharmaceutically active ingredient is ibuprofen and at least one low solubility filler is microcrystalline cellulose.

7 . A solid dose composition of claim 5 wherein the low solubility pharmaceutically active ingredient is ibuprofen, at least one low solubility filler is microcrystalline cellulose and at least one controlled release agent is Hypromellose.

8 . A solid dose composition of claim 4 wherein at least one of the low solubility pharmaceutically active ingredients is ibuprofen.

9 . A solid dose composition of claim 4 wherein at the low solubility pharmaceutically active ingredients is ibuprofen and the low solubility filler is microcrystalline cellulose.

10 . A method of manufacturing a solid dose composition of claim 3 wherein at least one of the low solubility pharmaceutically active ingredients is ibuprofen.

11 . A solid dose composition of claim 3 wherein at least one of the controlled release agents is hydroxypropylmethylcellulose.

12 . A solid dose composition of claim 3 wherein at least one of the controlled release agents is hydroxypropylmethylcellulose and wherein at least one of the low solubility pharmaceutically active ingredients is ibuprofen.

13 . A method of manufacturing a solid dose composition of claim 2 wherein at least one of the low solubility pharmaceutically active ingredients is ibuprofen.

14 . A method of manufacturing a solid dose composition of claim 2 wherein at least one of the controlled release agents is hydroxypropylmethylcellulose.

15 . A method of manufacturing a solid dose composition of claim 2 wherein at least one of the controlled release agents is hydroxypropylmethylcellulose and wherein at least one of the low solubility pharmaceutically active ingredients is ibuprofen.

16 . A method of manufacturing a solid dose composition of claim 2 wherein at least one of the controlled release agents is hydroxypropylmethylcellulose, wherein at least one of the low solubility pharmaceutically active ingredients is ibuprofen and wherein at least one of the low solubility fillers is microcrystalline cellulose.